Literature DB >> 29752079

Gemcitabine-loaded gold nanospheres mediated by albumin for enhanced anti-tumor activity combining with CT imaging.

Zhiming Wang1, Lina Chen2, Zhongyun Chu1, Chusen Huang1, Yuankui Huang2, Nengqin Jia3.   

Abstract

Currently, the development of a more effective therapy approach overcoming the resistance to chemotherapy for lung cancer still faces great challenges and requires further investigation. Herein, we fabricated gemcitabine (Gem) loaded gold nanospheres mediated by bovine serum albumin (Au@BSA) for the efficient delivery of therapeutic agents into the human pulmonary carcinoma cells (A549) and simultaneous computed tomography (CT) imaging. These nanoparticles (Au@BSA) with an approximate diameter of 10 nm were single crystals and prepared through a protein-directed facile one-pot synthesis via the reduction of chloroauric acid (HAuCl4) utilizing bovine serum albumin (BSA) as the stabilizer. The resulting positive charged Au@BSA nanospheres were conjugated with the negative Gem which served as the chemotherapeutic payload by electrostatic layer-by-layer assembling interactions to form Au@BSA-Gem. Our results demonstrated that the obtained biomimetic Au@BSA nanospheres were biocompatible with low cytotoxicity while the Gem-loaded ones exhibited obvious effects with efficiencies significantly greater than that of the free Gem.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-tumor; Computed tomography; Gemcitabine; Gold nanosphere; Lung cancer

Mesh:

Substances:

Year:  2018        PMID: 29752079     DOI: 10.1016/j.msec.2018.03.025

Source DB:  PubMed          Journal:  Mater Sci Eng C Mater Biol Appl        ISSN: 0928-4931            Impact factor:   7.328


  7 in total

1.  Horseradish Peroxidase-Functionalized Gold Nanoconjugates for Breast Cancer Treatment Based on Enzyme Prodrug Therapy.

Authors:  Gema Vivo-Llorca; Ángela Morellá-Aucejo; Alba García-Fernández; Paula Díez; Antoni Llopis-Lorente; Mar Orzáez; Ramón Martínez-Máñez
Journal:  Int J Nanomedicine       Date:  2022-01-26

2.  RGDV-modified gemcitabine: a nano-medicine capable of prolonging half-life, overcoming resistance and eliminating bone marrow toxicity of gemcitabine.

Authors:  Wenchao Liu; Yujia Mao; Xiaoyi Zhang; Yaonan Wang; Jianhui Wu; Shurui Zhao; Shiqi Peng; Ming Zhao
Journal:  Int J Nanomedicine       Date:  2019-09-06

3.  Resveratrol loaded glycyrrhizic acid-conjugated human serum albumin nanoparticles for tail vein injection II: pharmacokinetics, tissue distribution and bioavailability.

Authors:  Mingfang Wu; Chen Zhong; Yiping Deng; Qian Zhang; Xiaoxue Zhang; Xiuhua Zhao
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 4.  Emerging pro-drug and nano-drug strategies for gemcitabine-based cancer therapy.

Authors:  Haijie Han; Su Li; Yueyang Zhong; Yue Huang; Kai Wang; Qiao Jin; Jian Ji; Ke Yao
Journal:  Asian J Pharm Sci       Date:  2021-07-01       Impact factor: 6.598

Review 5.  Metal-based nano-delivery platform for treating bone disease and regeneration.

Authors:  Yanhua Liu; Zhengyi Xu; Mingxin Qiao; He Cai; Zhou Zhu
Journal:  Front Chem       Date:  2022-08-09       Impact factor: 5.545

Review 6.  Capping gold nanoparticles with albumin to improve their biomedical properties.

Authors:  Karen Bolaños; Marcelo J Kogan; Eyleen Araya
Journal:  Int J Nanomedicine       Date:  2019-08-09

7.  Exploring the action of RGDV-gemcitabine on tumor metastasis, tumor growth and possible action pathway.

Authors:  Xiaoyi Zhang; Jinhuan Zhang; Wenchao Liu; Yaonan Wang; Jianhui Wu; Shurui Zhao; Ming Zhao; Shiqi Peng
Journal:  Sci Rep       Date:  2020-09-25       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.